
EAACI Hong Kong Allergy School 2025: A Landmark In Global Allergy Education
Under the theme“East Meets West”, the 2025 edition of the Allergy School represents a bold step in fostering cross-continental collaboration in allergy and clinical immunology. By bringing together leading global experts, this flagship event aims to enrich knowledge exchange, advance clinical practices, and inspire innovative solutions to allergy care worldwide.
Participants will benefit from a rich, interdisciplinary scientific programme, featuring renowned international faculty and cutting-edge topics across the allergy and immunology spectrum. A special dedicated Chinese-language track will be available, promoting inclusivity and greater accessibility for Chinese-speaking professionals.
Attendees will also present their research through oral and poster sessions, connect with industry leaders, and build lasting collaborations within the global allergy community. Prizes will be awarded to top abstracts as selected by EAACI's international panel of experts.
In celebration of this milestone, EAACI is offering exclusive benefits:
- Discounted registration for current EAACI members A complimentary 1-year EAACI membership for registered delegates that are not EAACI members
We invite you to submit your abstracts and take advantage of early bird registration, available now. The abstract submission deadline is 31st May 2025.
As we gather to celebrate innovation, partnership, and progress, we also invite you to experience the vibrant city of Hong Kong – its iconic skyline, diverse cuisine, and cultural richness – the perfect setting for this global exchange.
Join us in shaping the future of allergy science and care. Your participation will help build a thriving; interconnected network of professionals dedicated to better outcomes for patients everywhere.
Explore the programme, register, and plan your visit at:
About EAACI
The European Academy of Allergy and Clinical Immunology (EAACI) is the leading professional organization dedicated to excellence in allergy and immunology. Learn more at .
Contact: ...
+41 44 205 55 33


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Metrika And S&P Global Ratings Conclude Proof-Of-Concept For Multi-Chain Digital Asset Risk Framework
- Signalrank Marks Two-Year Milestone With Strong Performance, Announces V4 Of Investment Selection Model
- Canelo Álvarez Joins 1Win As Global Ambassador After Historic Title Victory
- Team Behind Popular Telegram Wallet Grindery Reveals Wallet Infra For AI Agents
- AR.IO Launches Credit Card Payments For Web3 Identity And Hosting On Arweave
- Coinmarketcap Introduces CMC Launch, Elite Pre-TGE Project Launchpad, With Aster As Inaugural Project
Comments
No comment